Organisation paid for research Program year 2025 Source: CMS Open Payments

Immunoe Research Centers

Neither a doctor nor a teaching hospital

Research payments

$947,922

404 payments

Through program year 2025, Immunoe Research Centers is reported as receiving $947,922 in research payments, across 404 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$44,722	12
2024	Research	$133,879	62
2023	Research	$181,760	57
2022	Research	$208,329	238
2021	Research	$160,592	4
2020	Research	$102,300	11
2019	Research	$116,340	20

Breakdown

Who paid Research payments · program years 2019–2025

Octapharma USA, Inc. $318,518 14 payments
ACADIA Pharmaceuticals Inc $314,226 51 payments
ADMA BioManufacturing LLC $172,008 231 payments
LEO Pharma AS $59,895 17 payments
Amgen Inc. $42,168 5 payments
Dermavant Sciences, Inc. $23,329 73 payments
AbbVie, Inc. $9,054 6 payments
Aerin Medical Inc. $7,800 2 payments
Teva Pharmaceuticals USA, Inc. $804 3 payments
Merck Sharp & Dohme Corporation $119 2 payments

Studies the money was for Research payments · program years 2019–2025

Acp-103-069 $173,935 21 payments
A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17) $172,008 231 payments
Cutaquig Registry $160,206 2 payments
Acp-103-070 $123,341 29 payments
Pans Study $81,078 2 payments
Gam5-28 $49,946 6 payments
Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children $32,118 10 payments
ASCEND P3 AD Extension $25,601 2 payments
Scgam-03 $23,789 3 payments
Tralokinumab Vaccine Response Time $18,469 5 payments

What the money was spent on Research payments · program years 2019–2025

Patient care $172,008 231 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.